Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States. The company offers ARCUS, a genome editing platform to DNA genome insertion, deletion, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; PBGENE-PMM for the treatment of m.3243 associated primary mitochondrial myopathy (PMM) which is expected to submit an IND and/or CTA. In addition, it develops PBGENE-NVS for sickle cell disease/beta thalassemia for insertion; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LL2 (insertion), a liver directed target; PBGENE-LL3, a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. The company has license and collaboration agreement with Caribou Biosciences, Inc.; license agreement with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; development and license agreement with Eli Lilly and Company for the research and development of potential in vivo therapies for genetic disorders; Cellectis S.A.; iECURE, Inc. to develop ARCUS-based gene-insertion therapies; Duke University; and Novartis Pharma AG to discover and develop in vivo gene editing products. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. more
Time Frame | DTIL | Sector | S&P500 |
---|---|---|---|
1-Week Return | -25.99% | -3.39% | -3.47% |
1-Month Return | -43.11% | -3.25% | -0.29% |
3-Month Return | -56.98% | -11.61% | 4.5% |
6-Month Return | -59.11% | -5.89% | 6.91% |
1-Year Return | -60.89% | 2.65% | 23.79% |
3-Year Return | -98.32% | 0.56% | 28.43% |
5-Year Return | -98.87% | 34.63% | 83.64% |
10-Year Return | -99.21% | 94.78% | 185.94% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 22.24M | 24.29M | 115.53M | 25.10M | 48.73M | [{"date":"2019-12-31","value":19.25,"profit":true},{"date":"2020-12-31","value":21.02,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":21.72,"profit":true},{"date":"2023-12-31","value":42.18,"profit":true}] |
Cost of Revenue | - | - | - | 9.00M | 8.26M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.68,"profit":true}] |
Gross Profit | 22.24M | 24.29M | 115.53M | 16.09M | 40.47M | [{"date":"2019-12-31","value":19.25,"profit":true},{"date":"2020-12-31","value":21.02,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":13.93,"profit":true},{"date":"2023-12-31","value":35.03,"profit":true}] |
Gross Margin | 100.00% | 100.00% | 100.00% | 64.12% | 83.06% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":64.12,"profit":true},{"date":"2023-12-31","value":83.06,"profit":true}] |
Operating Expenses | 109.44M | 134.11M | 154.93M | 125.46M | 92.46M | [{"date":"2019-12-31","value":70.64,"profit":true},{"date":"2020-12-31","value":86.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":80.98,"profit":true},{"date":"2023-12-31","value":59.68,"profit":true}] |
Operating Income | (87.20M) | (109.83M) | (39.40M) | (100.37M) | (43.74M) | [{"date":"2019-12-31","value":-8720400000,"profit":false},{"date":"2020-12-31","value":-10982800000,"profit":false},{"date":"2021-12-31","value":-3940200000,"profit":false},{"date":"2022-12-31","value":-10036600000,"profit":false},{"date":"2023-12-31","value":-4373600000,"profit":false}] |
Total Non-Operating Income/Expense | (1.59M) | 1.64M | 8.88M | 29.82M | 6.87M | [{"date":"2019-12-31","value":-5.33,"profit":false},{"date":"2020-12-31","value":5.51,"profit":true},{"date":"2021-12-31","value":29.77,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":23.03,"profit":true}] |
Pre-Tax Income | (92.88M) | (109.01M) | (30.60M) | (111.64M) | (42.53M) | [{"date":"2019-12-31","value":-9287700000,"profit":false},{"date":"2020-12-31","value":-10900600000,"profit":false},{"date":"2021-12-31","value":-3060200000,"profit":false},{"date":"2022-12-31","value":-11163700000,"profit":false},{"date":"2023-12-31","value":-4252700000,"profit":false}] |
Income Taxes | (9.58M) | 10.43M | 316.00K | 11.27M | 27.24M | [{"date":"2019-12-31","value":-35.16,"profit":false},{"date":"2020-12-31","value":38.29,"profit":true},{"date":"2021-12-31","value":1.16,"profit":true},{"date":"2022-12-31","value":41.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (83.30M) | (119.43M) | (30.92M) | (122.91M) | (69.77M) | [{"date":"2019-12-31","value":-8330100000,"profit":false},{"date":"2020-12-31","value":-11943470300,"profit":false},{"date":"2021-12-31","value":-3091800000,"profit":false},{"date":"2022-12-31","value":-12290800000,"profit":false},{"date":"2023-12-31","value":-6976500000,"profit":false}] |
Income From Continuous Operations | (92.88M) | (109.01M) | (30.60M) | (111.64M) | (87.25M) | [{"date":"2019-12-31","value":-9287700000,"profit":false},{"date":"2020-12-31","value":-10900600000,"profit":false},{"date":"2021-12-31","value":-3060200000,"profit":false},{"date":"2022-12-31","value":-11163700000,"profit":false},{"date":"2023-12-31","value":-8724800000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (83.30M) | (109.01M) | (30.92M) | (122.91M) | (61.32M) | [{"date":"2019-12-31","value":-8330100000,"profit":false},{"date":"2020-12-31","value":-10900600000,"profit":false},{"date":"2021-12-31","value":-3091800000,"profit":false},{"date":"2022-12-31","value":-12290800000,"profit":false},{"date":"2023-12-31","value":-6131900000,"profit":false}] |
EPS (Diluted) | (3.15) | (2.09) | (0.68) | (1.40) | (4.46) | [{"date":"2019-12-31","value":-315,"profit":false},{"date":"2020-12-31","value":-209,"profit":false},{"date":"2021-12-31","value":-68,"profit":false},{"date":"2022-12-31","value":-140,"profit":false},{"date":"2023-12-31","value":-446,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
DTIL | |
---|---|
Cash Ratio | 8.45 |
Current Ratio | 9.22 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
DTIL | |
---|---|
ROA (LTM) | -6.38% |
ROE (LTM) | 24.44% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
DTIL | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.58 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
DTIL | |
---|---|
Trailing PE | 10.32 |
Forward PE | 2.11 |
P/S (TTM) | 0.42 |
P/B | 0.49 |
Price/FCF | NM |
EV/R | 0.18 |
EV/Ebitda | NM |
Precision BioSciences Inc (DTIL) share price today is $4.521
Yes, Indians can buy shares of Precision BioSciences Inc (DTIL) on Vested. To buy Precision BioSciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DTIL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Precision BioSciences Inc (DTIL) via the Vested app. You can start investing in Precision BioSciences Inc (DTIL) with a minimum investment of $1.
You can invest in shares of Precision BioSciences Inc (DTIL) via Vested in three simple steps:
The 52-week high price of Precision BioSciences Inc (DTIL) is $19.43. The 52-week low price of Precision BioSciences Inc (DTIL) is $4.13.
The price-to-earnings (P/E) ratio of Precision BioSciences Inc (DTIL) is 10.325
The price-to-book (P/B) ratio of Precision BioSciences Inc (DTIL) is 0.49
The dividend yield of Precision BioSciences Inc (DTIL) is 0.00%
The market capitalization of Precision BioSciences Inc (DTIL) is $31.68M
The stock symbol (or ticker) of Precision BioSciences Inc is DTIL